Category	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Revenue	488,600	534,612	664,717	727,476	844,583	953,951	1,045,049
Operating Profit	19,015	5,837	-2,447	7,713	-47,076	-9,567	-59,684
Net Profit	36,097	52,368	-34,179	-21,844	-69,659	-5,560	-14,550

Balance Sheet (Consolidated)

Unit: Million won

Category	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Total Assets	947,532	1,162,923	1,313,710	1,535,125	1,607,008	1,725,570	2,194,379
Total Liabilities	397,285	496,625	676,834	742,013	955,072	1,069,236	1,475,529
Total Equity	550,247	666,298	636,876	793,112	651,936	656,334	718,849

CHA Biotech Revenue (Separate)

Unit: 100 million won

CAGR 21%

Income Statement (Separate)

Unit: Million won

Category	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Revenue	26,793	30,320	26,760	35,288	42,326	69,178	54,009
Operating Profit	-2,164	-308	273	-1,757	-879	17,806	-339
Net Profit	-13,311	43,798	-7,080	-8,818	-61,893	1,407	52,696

Balance Sheet (Separate)

Unit: Million won

Category	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Total Assets	283,637	320,193	390,989	398,180	395,402	426,432	704,706
Total Liabilities	86,244	80,913	157,391	87,533	145,880	175,034	401,307
Total Equity	197,392	239,279	233,597	310,647	249,521	251,397	303,399

CHA Network

[Main Office] CHA Bio Complex, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488

Affiliates

Global Healthcare

Business